Read More Pharma Industry News Wockhardt’s Zaynich achieves record-breaking 96.8% clinical cure rate in cUTI Phase III trial Wockhardt Limited has announced a major breakthrough in the treatment of complicated urinary tract infections (cUTI) with its… byPallavi MadhirajuJanuary 31, 2025